AI assistant
BIODESIX INC — Director's Dealing 2025
Nov 13, 2025
34472_dirs_2025-11-13_f02208c0-ffb7-447d-8188-c72ba2e18394.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2025-11-10
Reporting Person: O'Kane Kieran (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-10 | Common Stock | M | 75 | — | Acquired | 7387 | Direct |
| 2025-11-10 | Common Stock | S | 25 | $7.62 | Disposed | 7362 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-10 | Restricted Stock Units | $ | M | 75 | Disposed | Common Stock (75) | Direct |
Footnotes
F1: These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the "Reverse Stock Split").
F2: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F3: Includes 309 shares of the Issuer's Common Stock, as adjusted for the Reverse Stock Split, purchased under the Issuer's Employee Stock Purchase Plan on September 2, 2025.
F4: These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
F5: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.